Tevogen announced that its artificial intelligence initiative, Tevogen.AI, is expanding its collaboration with Microsoft and Databricks, to build the beta version of its foundational...
Calidi Biotherapeutics, a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, announced the appointment of Guy Travis Clifton, MD as Chief...
Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat oncology and autoimmune diseases, announced the appointment of Joseph Bolen, Ph.D., as...
IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced a research collaboration with ATTMOS as...
AbbVie and Xilio Therapeutics, Inc., a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced a collaboration...
